Back to search
Cerebral Adrenoleukodystrophy (cALD)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cerebral Adrenoleukodystrophy (cALD) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Cerebral Adrenoleukodystrophy (cALD) trials you may qualify forA Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adults Male Subjects with Cerebral Adrenoleukodystrophy.
The main aim of this study is to assess and describe the safety outcomes, including newly diagnosed malignancies, of patients with CALD treated with eli-cel in…
This is a Phase 1/2 randomized, blinded, dose-escalation study to evaluate the safety and efficacy of intrathecal (IT) administration of SBT101, a recombinant a…
The course of AMN-related disabilities over time is poorly or incompletely understood due to a limited number of patients and lack of treatments. This study wil…